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A B S T R A C T
Oxysterols are bioactive lipids that act as regulators of lipid metabolism, inflammation, cell viability and are
involved in several diseases, including atherosclerosis. Mounting evidence linked the atherosclerosis to en-
dothelium dysfunction; in fact, the endothelium regulates the vascular system with roles in processes such as
hemostasis, cell cholesterol, hormone trafficking, signal transduction and inflammation. Several papers shed
light the ability of oxysterols to induce apoptosis in different cell lines including endothelial cells. Apoptotic
endothelial cell and endothelial denudation may constitute a critical step in the transition to plaque erosion and
vessel thrombosis, so preventing the endothelial damaged has garnered considerable attention as a novel means
of treating atherosclerosis. Endoplasmic reticulum (ER) is the site where the proteins are synthetized and folded
and is necessary for most cellular activity; perturbations of ER homeostasis leads to a condition known as en-
doplasmic reticulum stress. This condition evokes the unfolded protein response (UPR) an adaptive pathway that
aims to restore ER homeostasis. Mounting evidence suggests that chronic activation of UPR leads to cell dys-
function and death and recently has been implicated in pathogenesis of endothelial dysfunction. Autophagy is an
essential catabolic mechanism that delivers misfolded proteins and damaged organelles to the lysosome for
degradation, maintaining basal levels of autophagic activity it is critical for cell survival. Several evidence
suggests that persistent ER stress often results in stimulation of autophagic activities, likely as a compensatory
mechanism to relieve ER stress and consequently cell death. In this review, we summarize evidence for the effect
of oxysterols on endothelial cells, especially focusing on oxysterols-mediated induction of endoplasmic reticulum
stress.
1. Introduction
The endothelial cell (EC) lining of vessels walls is a critical reg-
ulatory component of cardiovascular homeostasis that can be seen as an
organ supporting important functions. On one hand, it influences vas-
cular tone and inhibits coagulation and platelet activation allowing the
blood to flow in the vessel conduits. Among others, endothelial cells
produce nitric oxide and prostacyclin that modulate function of cells
both in the intravascular compartment, i.e platelets, and in the vessel
wall, i.e smooth muscle cells. On the other hand, the endothelial lining
is the gate to the interstitial space for nutrients and cells of the immune
system. Alteration in the EC barrier function has important implications
in precipitating the loss of vascular homeostasis. The term endothelial
dysfunction is used to refer to diverse changes in endothelial cell me-
tabolism that are a prerequisite to triggering the mechanisms of athero-
thrombosis, which is the underlying cause of the myocardial infarction,
stroke, unstable angina, and sudden cardiac death [1]. EC dysfunction
occurs in conditions of high blood cholesterol and glucose levels, in
insulin resistance, and in conditions of up-regulated oxidative stress.
It is well established that atherosclerotic lesions develop in a non-
random fashion typically around areas where blood vessels branch or
curve. Physical computational models have determined that these sus-
ceptible regions have low time-average shear stress, a high oscillatory
shear index, and a steep temporal and spatial gradient in shear stress. In
contrast, unbranched arteries that are exposed to uniform laminar shear
stress largely do not develop lesions [2].
Fluid dynamics in atherosclerosis-prone areas translates into im-
paired barrier function and higher rates of turnover and senescence
compared with cells present in atherosclerosis-resistant regions.
Among the potential drivers of EC dysfunction, recent evidence
highlighted the role of endoplasmic reticulum stress (ERS).
Atherosclerotic plaques express markers of chronic ERS [3] that
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precipitate apoptosis and eventually promote athero-thrombosis me-
chanisms. It is plausible that ERS may promote atherosclerosis by in-
itially causing cell dysfunction and later inducing endothelial apoptosis
[4].
The early detectable changes of atherosclerosis focus on endothelial
dysfunction that favors the transfer and modification of circulating li-
poproteins into the sub-endothelial space. In particular, free radicals
and the oxidative modification of low-density lipoprotein (LDL) are
mediators for inflammatory cells recruitment and foam cell formation.
Oxidized-LDLs (Ox-LDL) induce different biological effects in cultured
vascular cells depending on several factors, including the nature of the
oxidized lipids [5]. LDLs are the main carriers of cholesterol in the
circulation and are very prone to oxidative insult. Oxidation of the lipid
components transported by LDL includes cholesterol that is transformed
into a number of oxysterols, biologically active products that are
emerging candidates in several disease settings [6].
Given the central role of endoplasmic reticulum (ER) pathway in
cellular metabolism and function, and the bioactivity of oxysterols in
the context of atherosclerosis, this review focuses on the potential links
between of oxysterols on the ER pathway.
2. Endoplasmic reticulum physiology
The ER plays a central role in lipid and protein and synthesis, and
governs several signaling pathways by controlling Ca2+ movements. ER
is composed by a series of continuous membranes organized into sub-
domains that include the rough-, smooth- and transitional-ER, and the
nuclear envelope. The rough ER, which is mainly laminar, is associated
with polyribosomes for protein synthesis and Ca2+ signaling. The
smooth ER is primarily composed of tubular structures providing the
site of lipid biosynthesis, has a main role in Ca2+ signaling, and is re-
ferred as the chief point of contact with other organelles [7].
The ER is the main cellular biosynthesis compartment of a variety of
lipids - including phospholipids, cholesterol and ceramides – subse-
quently transported to others organelles and cellular membranes via
vesicles of the secretory pathway [8]. The ER is involved in monitoring
lipid membrane composition, helping to activate appropriate responses
to preserve lipid homeostasis. Newly synthesized proteins are trans-
ferred into the ER to sustain specific modification, including folding,
glycosylation and disulfide bond formation [9]. The ER quality control
system prevents protein aggregation by promoting correct folding or
selective degradation of the improperly folded polypeptide [10]. The
varied ER functions are tightly connected. For example, an accumula-
tion of misfolded proteins can alter Ca2+ homeostasis and, vice versa, a
change in the luminal content of Ca2+ has a major effect on the process
of protein synthesis [11]. Up to 30% of all proteins in the eukaryotic
cells are targeted to the secretory pathway. Proteins destined for se-
cretion are translocated across or inserted into the ER membrane,
whereupon they fold and assemble to their native state before being
transported to the Golgi apparatus. Proteins that fail to fold correctly
are translocated back across the ER membrane to the cytosol where
they become substrates for a cytosolic degradation machinery, the
proteasome, in a process known as ER-associated degradation (ERAD)
[12,13].
The ER is capable of both signal reception and signal transmission.
The input signals include Ca2+, inositol 1,4,5-triphosphate, sphingo-
sine-1-phosphate, reactive oxygen species (ROS), and sterols. In re-
sponse to these input signals, the ER generates a variety of output
signals such as Ca2+ transients, activators of store-operated channels,
stress signals, arachidonic acid metabolites, and various transcription
factors (NF-kB, CHOP, ATF6, and SREBPs). Structural differences in the
organelle morphology correlate with differences in ER function [7]. As
mentioned above the ER serves as a nexus for the folding and ma-
turation of proteins that transit to secretory pathways. Protein folding is
both regulated and sensed by ER resident chaperones, such as GRP78/
BiP and GRP94 [14–17]. GRP78 was first discovery as a 78,000 Da
protein whose synthesis was enhanced in cultured cells grown in
medium deprived of glucose. Subsequently, GRP78 was determined to
be an ER resident protein whose synthesis could be stimulated by a
variety of environmental and physiological stress conditions able to
perturb ER function and homeostasis. GRP78, commonly referred to as
BiP, the immunoglobulin heavy chain-binding protein, is a well estab-
lished marker of ER stress (ERS) [18]. GRP94, like GRP78, participates
in protein folding, interacts with other components of the ER protein
folding machinery, governs calcium storage, and assists the targeting of
misfolded proteins to ERAD [19,20]. Compared to GRP78, the client
proteins of GRP94 are more selective and have critical roles in im-
munity, growth signaling, and cell adhesion.
3. ER stress
In the last decade, several studies showed that lipid oxidation pro-
ducts, including oxysterols, contribute to trigger ERS and eventually
play a key role in the progression of atherosclerosis [4,21,22]. In par-
ticular, activation of different ERS markers has been demonstrated to
occur in endothelial cells exposed to oxysterols and ox-LDL. Proteins are
particularly vulnerable to oxidative stress. It has been estimated that
under oxidative stress 69% of proteins are oxidized compared to 31%
that accounts for lipids and DNA [23]. Free radicals-derived protein
modification can result in either gain- or loss-of-function due to the
protein misfolding or unfolding [24–26]. Given that proteins are the
machinery that virtually performs all major cellular functions, it is not
surprising that cells invest a significant energetic effort to retain a fully
functional proteome. Cells placed under proteotoxic stress activate
specific and integrated cellular pathways involved in maintaining the
integrity of the proteome. This is referred to as the proteostasis network
that is composed of several protein quality control machineries, which
under conditions of proteotoxic stress aims at rescuing or degrading
unfolded, misfolded or non-native polypeptides. The first function is
usually accomplished by molecular chaperones, while the ubiquitin
proteolytic system is mainly responsible for protein degradation.
Protein misfolding in the ER is sensed by the unfolded protein re-
sponse (UPR), a signaling network able to re-establish homeostasis of
the protein folding function. UPR induces the synthesis of folding cat-
alysis to increase folding activity and attenuates the global translation
to reduce folding load. On the other hand, ERAD eliminates misfolded
proteins from the ER. Removal of abnormal protein products by ERAD
occurs after their selective retro-translocation into the cytosol where
they are degraded by the ubiquitin proteasome system (UPS) [12,13].
The UPS, which is highly coordinated with autophagy to maintain
cellular homeostasis [27], specifically targets proteins for proteasomal
degradation by adding the small polypeptide ubiquitin (Ub) at various
lysine residues. The UPS pathway ensures high levels of specificity in
labeling proteins for degradation through three classes of enzymes - E1
Ub-activating, E2 Ub-conjugating, and E3 Ub-ligase. ER substrates are
ubiquitinated on the cytosolic side of the ER by ER-transmembrane E3
Ub-ligases. In the context of ERAD, Ub tagging serves for proteasome
recognition, and as a signal for the retro-translocation and regulation of
the ERAD machinery components. In addition, ubiquitinated proteins
can be selectively degraded by autophagy. Suppression of the UPS
pathway by siRNA is offset by an increase in autophagy. However, in-
hibition of autophagy results in inhibited degradation of UPS substrate.
4. UPR in the regulation of ER stress
In higher eukaryotes ER is constantly monitored by at least three ER
trans-membrane sensors, each initiating a set of distinct but intersecting
signaling pathways oriented in maintaining ER homeostasis. The trans-
membrane sensors acting as transducers of ER stress signaling include
the serine/threonine kinase and endoribonuclease IRE1; PERK serine/
threonine kinase (also referred as PEK); and the basic leucine-zipper
transcription factor ATF6. The first pathway is the IRE1 pathway, which
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regulates the transcriptional induction of genes encoding ERAD com-
ponents. IRE1 is a type I trans-membrane protein residing on the ER
membrane [28–31], whose cytosolic portion contains kinase and RNase
domains [32–34]. IRE1 is an inactive monomer in normal growth
conditions, but becomes an active oligomer and forms clusters on the
ER membrane in response to ER stress [35,36]. IRE1 oligomers auto-
phosphorylate each other to activate the RNase domain. IRE1 cleaves
the pre-mRNA of XBP1 at two levels, and an unidentified RNA-ligase
binds the two exons of the XBP1 mRNA, resulting in splicing of XBP1
mRNA and the excision of a small intron [37–39]. Because the length of
the intron is 26 nt, splicing of XBP1 mRNA by IRE1 causes a frame shift.
Thus, the pre-mRNA and mature mRNA of XBP1 encode different pro-
teins, pXBP1(U) and pXBP1(S), respectively. pXBP1(S) is an active
transcription factor and contains both the DNA-binding domain and the
transcriptional activation domain. pXBP1(S) forms a heterodimer with
pATF6(N) and binds to the enhancer element called the unfolded pro-
tein response element, resulting in the transcriptional activation of
ERAD genes such as HRD1, EDEM and Derlins [40,41]. pXBP1(S) is a
very unstable protein that is degraded by the proteasome, unless bound
to UBC9 [42]. The second pathway is based on PERK, a sensor molecule
residing on the ER membrane [43,44]. The molecular structure of PERK
is similar to that of IRE1, but the cytosolic domain of the PERK contains
only the kinase domain. In the absence of ER stress, PERK is an inactive
monomer, whereas PERK becomes an active oligomer upon ER stress,
like IRE1. Activated PERK phosphorylates the α subunit of eukaryotic
transcriptional initiation factor (eIF2α), resulting in the inactivation of
eIF2α and translational attenuation, which prevents further accumu-
lation of unfolded proteins in the ER. ATF6, consisting of the closely
related ATF6α and ATF6β in mammals, is constitutively synthesized as
a type II trans-membrane protein in the ER, designed as pATF6 α/β.
Upon ERS, pATF6 α/β relocates from ER to the Golgi apparatus to be
cleaved by site-1 and site-2 proteases. The resulting cytoplasmic frag-
ment liberated from the membrane - designated pATF6 α/β (N) - enters
the nucleus to activate transcription of its target genes [45,46], such as
GRP78/BiP, CHOP and XBP1. In this manner ATF6 indirectly regulates
autophagy and apoptosis via XPB-1 and CHOP [47].
5. ER stress and autophagy
Oxidative stress and ERS are relevant factors in the mechanisms that
induce autophagy. Oxidative stress also triggers ERS that in turn in-
duces autophagy. A certain degree of autophagy brings to removal of
ubiquitinated unfolded/misfolded proteins and as a consequence re-
duces ER stress. However, excessive activation of autophagy after per-
severing ER stress can aggravate cell injury eventually leading to
apoptosis and cell self-digestion. Autophagy is a tightly regulated in-
tracellular bulk degradation/recycling system that has fundamental
roles in cellular homeostasis. Autophagy is a major catabolic process
that delivers proteins, cytoplasmic components, and organelles to ly-
sosomes for degradation and recycling. A well-orchestrated program
including over 30 AuTophaGy-related (ATG) genes controls autophagy,
which can be activated by nutrient starvation and subsequent inhibition
of mechanistic target of rapamycin (mTOR) signaling [48], or by the
UPR in response to accumulation of aggregated misfolded proteins
[49]. A long-standing question in the autophagy field is the origin of the
autophagosome membrane. Apparently, autophagy has a direct bidir-
ectional connection with the ER membrane. The double-layer lipid
membrane of autophagosomes most likely originates from two main
sources, the ER and mitochondria [50,51]. A peculiar form of ER stress-
induced autophagy is referred as reticulophagy, which is essential to
counterbalance ER expansion during UPR [52,53]. Recently, Ge and co-
workers [54] suggested the ER-Golgi intermediate compartment
(ERGIC) as the most efficient membrane substrate for LC3 lipidation.
The authors demonstrated that the ERGIC plays an essential role in
triggering LC3 lipidation and autophagosome biogenesis by recruiting
the key early autophagic factor ATG14. The ERGIC is a recycling
compartment characterized by a tubule-vesicular structure, which is
located between ER and cis-Golgi compartment, subjected to a constant
flux of membrane traffic. A subset of the ERGIC may became diverted to
specialized events such as the formation of phagophore membranes in
starved cells. Considering the location of the ERGIC, which is adjacent
to the ER, a burst initiation of autophagosome biogenesis could quickly
mobilize the ER for further membrane acquisition and expansion. Cel-
lular stress induced by different stimuli can activate several processes
aimed at either restoring cellular homeostasis or committing cell death.
ERS response, which includes UPR and autophagy, represents a me-
chanism used by the cell in the attempt of restoring the cellular
homeostasis. It is important to underline that the degree of initial insult,
often regarded as the degree of ERS and UPR activation, can determine
the balance between pro- and anti-survival signals, in which autophagy
may serve to either promote or attenuate ERS and UPR signals. In the
canonical ERAD system, ubiquitinated unfolded/misfolded proteins are
degraded by the UPS and the autophagic pathway is viewed as a sec-
ondary response to ERS. However, recent evidence suggests that au-
tophagy can be engaged both in the canonical and non-canonical ERAD
system. B’Chir et al. [55] showed that the eIF2α/ATF4 pathway drives
an autophagy gene transcriptional program in response to amino acid
starvation or ERS. The eIF2α kinases GCN2 PERK, the transcription
factors ATF4, and CHOP are also required to increase the transcription
of a set of genes implicated in the formation, elongation, and function
of autophagosome. Furthermore, Haberzettl et al. [56] showed that
IRE1 is also implicated in the activation of the autophagy. Increased
IRE1 activity and IRE1-dependent inflammation was observed in in-
testinal epithelial cells of ATG-knockout mice. This observation implies
that deregulated autophagy may also trigger IRE1 activation and con-
comitant activation of the sXBP arm of the UPR, suggesting a possible
feedback mechanism in the control of UPR signaling.
6. Oxysterols: metabolism and signaling
LDL are the main carriers of cholesterol in the circulation and are
very prone to oxidative insults. Oxidation of the lipid components
transported by LDL includes cholesterol that is transformed into a
number of biologically active oxysterols [6]. A mounting body of evi-
dence highlights the role of oxysterols in health and disease.
Diverse oxysterols are cytotoxic, induce apoptosis to cultured cells
[57], and are implicated in inflammatory diseases, atherosclerosis,
neurodegenerative diseases and cancer [22,58–60]. Pioneristic work by
Lizard et al. demonstrated that oxysterols are able to activate apoptotic
signaling pathways in endothelial cells [61,62], thus contributing to the
development of atherosclerosis. Notably, among investigated oxy-
sterols, 7beta-hydroxycholesterol and 7-ketocholesterol (7KC) were the
most potent inducers of apoptosis [63].
In addition, oxysterols are emerging candidates for the control of
cell function by acting as signaling molecules at cellular level [64]. For
example, 7KC through its ability to activate PKC (Protein Kinase C) is
able to block the release of NO from vascular endothelial cells thus
affecting the relaxation of arterial wall [65,66]. Moreover, several lines
of evidence suggest that oxysterols act as stressors that can lead to
prolonged activation of the UPR [4,5]. 7KC, in analogy to that observed
with LDL, has been shown to induce ER stress in human EC and mediate
apoptosis [67]. Several authors showed that changes in the antioxidant
status contribute to the induction of redox-sensitive transcription fac-
tors, which in turn trigger autophagy [68,69]. Lizard and co-workers
[70] reported that 7KC induces a mixed type of cell death on 158N
cells, associated to ROS overproduction, apoptosis and autophagy,
suggesting the new designation of “oxiapoptophagy”. Yuan et al. [71]
reported that the induction of autophagy, in a human monocytic cell
line, is associated to a significant reduction in 7KC- mediated cell death.
On the other hand, Muller [72] reported that ox-LDL induce the un-
folded protein response (UPR) and trigger ERS and autophagy in
HMEC-1 cells. The authors suggested that autophagy could act as anti-
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atherogenic mechanism by favouring the degradation of cellular com-
ponents after ox-LDL insult. In agreement, Yuan et al. [71] reported that
autophagy minimizes cellular lipid accumulation induced by oxysterols,
preventing the formation of atherosclerotic plaques.
Oxysterols induce the activation of several transcription factors that
appear to be redox modulated and are in connection with the ER.
Among them the most important and extensively characterized are the
LXRs. Activation of LXRs by oxysterols induces the expression of genes
involved in cellular cholesterol trafficking, including Niemann Pick
type C1 and 2 proteins, and cholesterol efflux, including ABCA1,
ABCG1 and apolipoprotein E [73]. Moreover, LXRs maintain choles-
terol homeostasis by suppressing LDL uptake through transcriptional
induction of Idol (inducible degrader of the LDL receptor), an E3 ubi-
quitin ligase that triggers ubiquitination of the LDL receptor. In addi-
tion, LXR is reportedly to regulate ER stress by dynamically modulating
the incorporation of polyunsaturated fatty acids into phospholipids
through the induction of Lpcat3 [74].
On the other hand, LXRs regulate fatty-acid-related genes, such as
FAS (fatty acid synthase), SCD (stearoyl-CoA desaturase), FADS (fatty
acid desatu-rase), ELOVL5 (elongation of long-chain fatty acids), and
SREBP1c (sterol regulatory element-binding protein 1c). SREBPs con-
trol cholesterol synthesis by a regulated transport from the ER to the
Golgi that is inhibited by oxysterols [75,76].
By modulating LXRs activity, oxysterols can negatively affect the
signaling of Toll like receptors (TLRs). Joseph et al. [77] demonstrated
that activation of LXRs by oxysterols in macrophages inhibits NF-κB
signaling and the consequent expression of TLR-inducible inflammatory
genes such as inducible nitric oxide synthase (iNOS), interleukin-1β,
and monocyte chemoattractant protein-1 in response to bacterial in-
fection or LPS stimulation. On the other hand, Gargiulo et al. [78] re-
cently reported an enhanced NF-κB nuclear translocation promoted by
the activation of TLRs in response to oxysterol treatment of promono-
cytic cells. In analogy, NF-kB activation in response to oxysterols has
been shown in bovine aortic endothelial cells by Umetani et al. [79]. In
this paper the pro-inflammatory effect exhibited by oxysterols was at-
tributed, at least in part, to the strong activation and nuclear translo-
cation of NF-κB promoted by the ERK/c-Jun N-terminal kinase (JNK)
pathway. Involvement of NF-kB in transducing proinflammatory signals
was also indirectly demonstrated in HUVEC exposed to a mixture of
oxysterols [80]. Thus, oxysterols appear to have proinflammatory ac-
tivity in resting cells, while they function as immunosuppressants upon
cell activation by inflammatory agents such as LPS.
According to recent reports [79,81] the pro-inflammatory effect
exhibited by oxysterols is based, at least in part, on the strong activation
and nuclear translocation of NF-κB, through the ERK/c-Jun N-terminal
kinase pathway.
Side-chain oxysterols are efficient ligands and/or activators of
SREBPs, which are synthesized and located on the ER membrane in an
inactive form. Nuclear translocation requires that the active N-terminal
region of the bHLH to be cleaved. The SREBP cleavage-activating pro-
tein (SCAP) and Insigs function as cholesterol and oxysterol sensors,
respectively. When the cellular cholesterol levels are depleted, SCAP
binds to and escorts SREBP in COPII vesicles to the Golgi apparatus,
where site 1 and site 2 proteases cleave the SREBPs [82,83]. Upon re-
storation of cellular cholesterol, Insig, a key regulator of ER membrane
proteins, traps and retains the SREBP–SCAP complex in the ER to in-
hibit SREBP cleavage in the Golgi. Interestingly, 25-hydroxycholesterol
was found to potently inhibit proteolytic processing of SREBPs, pre-
sumably by binding to Insig proteins. Therefore, oxysterols appear to
negatively regulate cholesterol cellular content by promoting efflux, by
limiting uptake through LXRs, and by inhibiting de novo synthesis
through SREBPs. In this regard, Shentu et al. [84] have shown that
exposure to ox-LDL in vitro, and in dyslipidemia in vivo, significantly
increases the stiffness of aortic endothelial cells, which in turn is as-
sociated with an increase in endothelial contractility, enhanced angio-
genic potential, and sensitivity to shear stress. The authors
hypothesized that ox-LDL induces endothelial dysfunction by inserting
oxysterols into the plasma membrane, resulting in the disruption of
cholesterol-rich membrane domains and causing endothelial stiffening
[84]. However, it cannot be excluded that the effects may be mediated
by the ability of oxysterols to affect cholesterol metabolism, although
total content of membrane-associated cholesterol resulted apparently
unaffected.
Another, possible target of oxysterols-mediated cell signaling is
nuclear factor-erythroid 2 p45-related factor 2 (Nrf2). Nrf2 is a master
transcriptional activator of protective genes. It activates transcription in
response to electrophiles and reactive oxygen species. Under normal
conditions, Nrf2 is constantly ubiquitinated by Keap1 (Kelch-like ECH-
associated protein 1)/Cul 3 (cullin RING E3 ligase complex) and de-
graded by the proteasome. Exposure to oxidative stress leads to Keap1
inactivation and Nrf2 stabilization. Nrf2 migrates into the nucleus
where it binds to the ARE (Antioxidant Response Element) sequences in
the promoter region of genes encoding key components of the glu-
tathione-based and thioredoxin-based anti-oxidant systems [85]. Al-
though Nrf2 activation in response to oxysterol-induced ROS produc-
tion has been reported in promonocitic cells [86], elevated expression
of Nrf2 has been observed in HUVECs only after exposure to ox-LDL,
but a direct evidence of oxysterol involvement in activating Nrf2 in
endothelial cells is still missing [87]. Nrf2 is thought to protect cells
against oxidative stress, and has displays anti-inflammatory and an-
giogenic functions in endothelial cells [88].
Oxysterols are also recognized by the OSBP and OSBP-related pro-
tein (ORP) family, which have been postulated as intracellular lipid
sensors or transporters, and carry targeting determinants for ER [89].
Finally, a very rapid increase in cytoplasmic Ca2+ is observed in re-
sponse to oxysterols in a time frame that precedes the increases in levels
of reactive oxygen species, or changes in gene expression [90].
7. ER stress and oxysterols
In the last two decades, the physiology and pathophysiology of the
ER has become a very active area of research due to the evidence that
malfunction of the ER stress response caused by aging, genetic muta-
tions, or environmental factors can result in various diseases [91]. The
involvement of ER stress in atherosclerosis initiation and progression
has been well established [92,93]. In addition, pro-atherogenic effects
of ERS have been reported almost in every cell types present in ather-
osclerotic lesions and in endothelial cells. To this regard Zeng et al. [94]
have demonstrated how the transient activation of XBP1 splicing is
related to EC proliferation, while sustained activation induced EC
apoptosis, cell loss from vessel walls, and atherosclerotic lesion devel-
opment.
Both physical factors (disturbed blood flow) and pro-atherogenic
molecules such as ox-LDL have been proposed to contribute to ER stress
in endothelial cells [95–98]. In human microvascular endothelial cells
activation of the ER stress sensors IRE1α, PERK and ATF6 and sub-
sequent activation of eIF2α, XBP1, CHOP and the chaperons Grp78,
Grp94 and ORP150 have been found associated to ox-LDL treatment
[67,72]. Significantly, ox-LDL also triggered the activation of autop-
hagic processes [72]. The evidence that ER stress takes part in the
apoptotic effect of ox-LDL through the Ire1α/c-Jun N-terminal kinase
pathway was demonstrated by the protective effect exerted by specific
small interfering RNAs and c-Jun N-terminal kinase inhibitors [67].
Similarly, induction of the unfolded protein response was observed in
bovine aortic endothelial cells (BAECs) exposed to ox-LDL, as demon-
strated by phosphorylation of PERK and increased expression of GRP78
[99], and in HUVEC [21]. In the latter case ox-LDL induced cell
apoptosis through activation of the ER stress sensors IRE1 and PERK,
and nuclear translocation of ATF6, in agreement with the results ob-
tained by Muller et al. [72] and Tao et al. [100]. Consistently, down-
stream pathways resulted activated as evidenced by the occurrence of
eIF2α phosphorylation, increased expression of JNK, XBP1 and
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chaperone GRP78, and up-regulation of the proapoptotic proteins
CHOP and Bcl-2 [21].
Although the link between ox-LDL and ER stress has been well es-
tablished by several reports, investigation of the activity/contribution
of the different oxidized components is still in its emphasis. As far as
oxysterols are concerned, several reports showed their ability to induce
sustained ER stress in different cell types and in different pathological
contexts. However, different oxysterols may elicit different cellular ef-
fects in a dose and cell-specific manner, highlighting the need of further
investigation. To the best of our knowledge, only in one case, a com-
parative analysis of the effects of ox-LDL and 7KC in endothelial cells
has been conducted [67]. The authors concluded that 7KC, used at
concentrations relevant to those generated during LDL oxidation, mi-
micked the effect of ox-LDL by triggering the phosphorylation of Ire1α
and eIF2α.
The molecular mechanism(s) used by oxysterols to induce ER stress
are largely unknown. By modulating cholesterol/lipid metabolism and
trafficking or by directly being inserted in ER membranes, oxysterols
could alter lipid packing/composition, which is expected to be detri-
mental to endothelial function (Fig. 1). Interestingly, perturbation of
the lipid composition could impair the folding of ER proteins, thereby
activating the UPR [101]. On the other hand, oxysterols may activate
the UPR by directly causing accumulation of unfolded proteins. Dong
et al., showed that ox-LDL oxidize sarcoplasmic/endoplasmic reticulum
Ca2+ ATPase (SERCA) causing its partial inactivation [102]. It is well
known that inhibitors of SERCA, such as thapsigargin induce a decrease
in ER calcium levels. When calcium levels are lowered in the ER, the
calcium-dependent ER chaperones, lose their activity, leading to the
accumulation of unfolded proteins [103].
Fig. 1. Schematic representation of oxysterols-
induced ER stress on endothelial cells. At least
three major signaling are involved in the UPR acti-
vation. Oxysterols may alter the lipid membrane
composition and oxidize SERCA channels. Oxysterols
are activators of SREBPs which are synthetized and
located on the ER membrane and can modulate the
activity of LXR. This last pathway can differently
affects the ER status.
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8. Concluding remarks
ER plays a central role in cell metabolism as it governs protein and
lipid synthesis, and controls Ca2+ movements. In response to oxidative
insult ER activate a series of responses aimed at preserving cell function
or drive signals towards apoptosis and autophagy. ER stress has been
implicated in EC dysfunction and atherothrombosis. Ox-LDL, which are
considered the initial insult that promotes vascular changes leading to
atherogenesis, and their oxidized lipids, are involved in ER stress.
Oxysterols, which are found in ox-LDL and in almost all biological
fluids, have been implicated in several pathophysiological processes
and are potential candidates in the mechanisms of ER stress. However,
detailed studies focusing on relevant physiological concentrations and
comparing the dose-dependent effect of the diverse oxysterols in in-
ducing ER stress is still lacking and deserve further investigation.
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